Total Visits

Views
Clinical experience with the integrase inhibitors Dolutegravir and Elvitegravir in HIV-infected patients: efficacy, safety and tolerance132

Total Visits Per Month

December 2019January 2020February 2020March 2020April 2020May 2020June 2020July 2020August 2020September 2020October 2020
Clinical experience with the integrase inhibitors Dolutegravir and Elvitegravir in HIV-infected patients: efficacy, safety and tolerance532532223141

File Visits

Views
Cid_Clinical.pdf120

Top country views

Views
United States69
Spain19
Germany15
France4
Taiwan4
South Korea2
Ukraine2
Vietnam2
China1
Kenya1

Top cities views

Views
Ashburn33
Fairfield16
A Coruña15
Cambridge4
Jacksonville4
Seattle4
Taipei4
Hanoi2
Seoul2
Castellón1